# FDA Inspection 1313390 - Allotex, Inc - April 01, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/allotex-inc/dfbda838-f07e-4294-8ad8-4b1b8afcc302
Source feed: FDA_Inspections

> FDA Inspection 1313390 for Allotex, Inc on April 01, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313390
- Company Name: Allotex, Inc
- Inspection Date: 2026-04-01
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1313390 - 2026-04-01](https://www.globalkeysolutions.net/records/fda_inspections/allotex-inc/3b6776e8-b974-4d13-a4b1-396fdfa8a8f0)
- [FDA Inspection 1074257 - 2018-11-08](https://www.globalkeysolutions.net/records/fda_inspections/allotex-inc/91c060e4-f75a-4f8d-bfc7-f14db6da6db5)

Company: https://www.globalkeysolutions.net/companies/allotex-inc/07e3fbc5-ad3c-4a9d-aafb-f7b1b48f2b36

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d